150 related articles for article (PubMed ID: 38189823)
1. TBC1D1 represses glioma progression by altering the integrity of the cytoskeleton.
Cai J; Jiang Y; Chen P; Liang J; Zhang Y; Yuan R; Fan H; Zhong Y; Cai J; Cheng S; Zhang Y
Aging (Albany NY); 2024 Jan; 16(1):431-444. PubMed ID: 38189823
[TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity.
Sun J; He D; Fu Y; Zhang R; Guo H; Wang Z; Wang Y; Gao T; Wei Y; Guo Y; Pang Q; Liu Q
J Exp Clin Cancer Res; 2021 Jun; 40(1):187. PubMed ID: 34099027
[TBL] [Abstract][Full Text] [Related]
3. SEPT7 overexpression inhibits glioma cell migration by targeting the actin cytoskeleton pathway.
Hou M; Liu X; Cao J; Chen B
Oncol Rep; 2016 Apr; 35(4):2003-10. PubMed ID: 26846171
[TBL] [Abstract][Full Text] [Related]
4. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract][Full Text] [Related]
5. Reduction of Akt2 inhibits migration and invasion of glioma cells.
Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
[TBL] [Abstract][Full Text] [Related]
6. Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells.
Jin SG; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
Oncol Rep; 2016 Jun; 35(6):3395-402. PubMed ID: 27109183
[TBL] [Abstract][Full Text] [Related]
7. Eupatilin inhibits glioma proliferation, migration, and invasion by arresting cell cycle at G1/S phase and disrupting the cytoskeletal structure.
Fei X; Wang J; Chen C; Ding B; Fu X; Chen W; Wang C; Xu R
Cancer Manag Res; 2019; 11():4781-4796. PubMed ID: 31213900
[No Abstract] [Full Text] [Related]
8. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
9. RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mTOR pathway.
Liang L; Zhao Z; Jin Q; Zhang S; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):80-86. PubMed ID: 37571896
[TBL] [Abstract][Full Text] [Related]
10. TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.
Zhu Y; Xu Y; Chen T; Zhang Y; Ma Q; Rauniyar S; Wang L; Shi H
Mol Neurobiol; 2021 May; 58(5):2118-2132. PubMed ID: 33411238
[TBL] [Abstract][Full Text] [Related]
11. Scinderin promotes glioma cell migration and invasion
Lin X; Zhao Z; Sun SP; Liu W
World J Clin Oncol; 2024 Jan; 15(1):32-44. PubMed ID: 38292665
[TBL] [Abstract][Full Text] [Related]
12. GPER stabilizes F-actin cytoskeleton and activates TAZ via PLCβ-PKC and Rho/ROCK-LIMK-Cofilin pathway.
Wang Z; Sun L; Liang S; Liu ZC; Zhao ZY; Yang J; Wang D; Yang DQ
Biochem Biophys Res Commun; 2019 Aug; 516(3):976-982. PubMed ID: 31277940
[TBL] [Abstract][Full Text] [Related]
13. PRP4 kinase induces actin rearrangement and epithelial-mesenchymal transition through modulation of the actin-binding protein cofilin.
Islam SU; Ahmed MB; Lee SJ; Shehzad A; Sonn JK; Kwon OS; Lee YS
Exp Cell Res; 2018 Aug; 369(1):158-165. PubMed ID: 29787735
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
[TBL] [Abstract][Full Text] [Related]
15. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.
Bai YH; Zhan YB; Yu B; Wang WW; Wang L; Zhou JQ; Chen RK; Zhang FJ; Zhao XW; Duan WC; Wang YM; Liu J; Bao JJ; Zhang ZY; Liu XZ
Cell Physiol Biochem; 2018; 48(4):1755-1770. PubMed ID: 30078018
[TBL] [Abstract][Full Text] [Related]
16. ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.
Wang Y; Guan G; Cheng W; Jiang Y; Shan F; Wu A; Cheng P; Guo Z
BMC Cancer; 2018 May; 18(1):599. PubMed ID: 29843637
[TBL] [Abstract][Full Text] [Related]
17. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
[TBL] [Abstract][Full Text] [Related]
19. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
[TBL] [Abstract][Full Text] [Related]
20. Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Ji B; Liu L; Guo Y; Ming F; Jiang J; Li F; Zhao G; Wen J; Li N
Comput Math Methods Med; 2021; 2021():5594973. PubMed ID: 33833824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
